2Liu L,Zhang Y,Liu G,et al.The Felodipine Event Reduction (FEVER) Study:a randomized long-term placebo-controlled trial in Chinese hypertensive patients[J].J Hypertens,2005,23(12):2157-2572.
3Sever PS,Dahlf B,Poulter NR,et al.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):a multicentre randomised controlled trial[J].Drugs,2004,64(2):43-60.
4Weber MA,Bakris GL,Dahlof B,et al.Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial:a hypertensive population at high cardiovascular risk[J].Blood Press,2007,16(1):13-19.
4Liu L, Zhang Y, Liu G, et al. FEVER Study Group. The Felodipine Event Reduction (FEVER) Study: a randomized long- term placebo-controlled trial in Chinese hypertensive patients. J Hypertens, 2005,23 : 2157-2572.
5Julius S, Kjeldsen SE, Weber M, et al. VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet, 2004,363:2022-2031.
6Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet ,2003,361 : 1149-1158.
7Weber MA, Bakris GL, Dahlof B, et al. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk. Blood Press ,2007,16 : 13-19.
8Wang JG, Li Y, Franklin SS, et al. Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers : a quantitative overview. Hypertension, 2007,50 : 181 - 188.
9Makino H, Haneda M, Babazono T, et al. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes : a post-hoc analysis of The Incipient to Overt: Angiotensin Ⅱ Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study. Hypertens Res,2008,31:657-664.
10Sharma A, Bagchi A, Kinagi SB, et al. Results of a comparative, phase Ⅲ, 12-week, muhicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed- dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage Ⅱ hypertension. Clin Ther, 2007,29 : 2667 -2676.
